At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CR crane
Trading 09-08 13:43:50 EDT
204.09
-0.60
-0.30%
High206.86Low202.82Vol123.44K
Open206.08D1 Closing204.69Amplitude1.98%
Mkt Cap11.75BTradable Cap9.95BTotal Shares57.60M
T/O25.33MT/O Rate0.25%Tradable Shares48.76M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

E KOCREF CR-REIT Receives Clean Audit Opinions and Posts Stable Earnings
TIPRANKS  ·  09-08 15:45
E KOCREF CR-REIT Receives Clean Audit Opinions and Posts Stable Earnings
Crane Director James L. L. Tullis Disposes of 400 Shares Worth $82,150
Reuters  ·  09-03
Crane Director James L. L. Tullis Disposes of 400 Shares Worth $82,150
CR Sanjiu Gets Registration Approval for 1 Billion Yuan Bonds
MT Newswires Live  ·  09-02
CR Sanjiu Gets Registration Approval for 1 Billion Yuan Bonds
Crane : Deutsche Bank Cuts Target Price to $240 from $248
THOMSON REUTERS  ·  09-01
Crane : Deutsche Bank Cuts Target Price to $240 from $248
CR Double-Crane Pharma Gets Registration Certificate for Oxcarbazepine Tablets
MT Newswires Live  ·  09-01
CR Double-Crane Pharma Gets Registration Certificate for Oxcarbazepine Tablets
U.S. Research Roundup-Autodesk, Hubspot, Oracle
Reuters  ·  09-01
U.S. Research Roundup-Autodesk, Hubspot, Oracle
E KOCREF CR-REIT Seeks Proxies Ahead of AGM as It Maintains High Dividend Payouts
TIPRANKS  ·  09-01
E KOCREF CR-REIT Seeks Proxies Ahead of AGM as It Maintains High Dividend Payouts
CR Mixc Lifestyle's Cash Flow, Expected Dividend Growth Reinforces Core Holding Status
Dow Jones  ·  08-31
CR Mixc Lifestyle's Cash Flow, Expected Dividend Growth Reinforces Core Holding Status
Stronger-Than-Expected Q2 Results And Higher EPS Guidance Might Change The Case For Investing In Crane (CR)
Simply Wall St.  ·  08-29
Stronger-Than-Expected Q2 Results And Higher EPS Guidance Might Change The Case For Investing In Crane (CR)
Press Release: InnoCare Reports 2026 Interim Results, Sustained Profitability and Key Milestones Achieved
Dow Jones  ·  08-24
Press Release: InnoCare Reports 2026 Interim Results, Sustained Profitability and Key Milestones Achieved
Press Release: Antengene Announces 2026 Interim Results: Achieves First
Dow Jones  ·  08-24
Press Release: Antengene Announces 2026 Interim Results: Achieves First
UroGen Submits NDA for UGN-103, an Investigational Treatment of Recurrent LG-IR-NMIBC
GlobeNewswire  ·  08-17
UroGen Submits NDA for UGN-103, an Investigational Treatment of Recurrent LG-IR-NMIBC
Crane Director James L. L. Tullis Sells 614 Shares for $138,150
Reuters  ·  08-15
Crane Director James L. L. Tullis Sells 614 Shares for $138,150
Press Release: Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Dow Jones  ·  08-15
Press Release: Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Press Release: Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Dow Jones  ·  08-15
Press Release: Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Moleculin Biotech Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of Pivotal MIRACLE Trial
GlobeNewswire  ·  08-14
Moleculin Biotech Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of Pivotal MIRACLE Trial
Press Release: Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
Dow Jones  ·  08-14
Press Release: Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
What Crane (CR)'s Acquisition-Fueled Guidance Hike Means For Shareholders
Simply Wall St.  ·  08-10
What Crane (CR)'s Acquisition-Fueled Guidance Hike Means For Shareholders
UroGen Reports $50.4 Million of ZUSDURI Revenue and Provides Second Quarter 2026 Financial Results and Highlights
GlobeNewswire  ·  08-05
UroGen Reports $50.4 Million of ZUSDURI Revenue and Provides Second Quarter 2026 Financial Results and Highlights
Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients
GlobeNewswire  ·  07-31
Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients

Introduction

Company Name.
crane
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Crane NXT, Co. focuses on payment and merchandising technologies. It indents to offer electronic equipment and associated software leveraging extensive, and proprietary core capabilities, including payment verification and authentication, as well as automation solutions, field service solutions, remote diagnostics, and productivity enhancing software solutions. The company is based in Stamford, Connecticut.
Issue price:
--